ERn Financial LLC Buys New Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

ERn Financial LLC purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 5,352 shares of the biotechnology company’s stock, valued at approximately $3,181,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AXON. Wolff Wiese Magana LLC boosted its position in shares of Axon Enterprise by 5.6% during the 4th quarter. Wolff Wiese Magana LLC now owns 625 shares of the biotechnology company’s stock worth $371,000 after acquiring an additional 33 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its stake in Axon Enterprise by 64.0% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,921 shares of the biotechnology company’s stock worth $1,736,000 after purchasing an additional 1,140 shares during the last quarter. Park Avenue Securities LLC boosted its holdings in Axon Enterprise by 11.3% in the fourth quarter. Park Avenue Securities LLC now owns 4,928 shares of the biotechnology company’s stock valued at $2,929,000 after purchasing an additional 502 shares in the last quarter. Assenagon Asset Management S.A. increased its stake in Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares during the last quarter. Finally, Board of the Pension Protection Fund purchased a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $1,308,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock worth $30,721,337 over the last 90 days. Company insiders own 5.70% of the company’s stock.

Analyst Ratings Changes

AXON has been the topic of a number of recent analyst reports. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Northland Securities raised their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC boosted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Finally, JMP Securities increased their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $504.92.

Axon Enterprise Stock Up 0.0 %

Shares of NASDAQ:AXON opened at $580.00 on Thursday. Axon Enterprise, Inc. has a fifty-two week low of $246.99 and a fifty-two week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm’s 50-day simple moving average is $612.80 and its 200-day simple moving average is $454.94. The company has a market cap of $44.23 billion, a price-to-earnings ratio of 149.87, a PEG ratio of 5.71 and a beta of 1.04.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.